Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Imaging and Spectroscopy of Radiation Chemistry in FLASH Radiotherapy to Inform Clinical Translation

Award Number: R01CA315651
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/12/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2030

Group Awards By:

View Award Description

Imaging and Spectroscopy of Radiation Chemistry in FLASH Radiotherapy to Inform Clinical Translation - FLASH radiotherapy (RT) is a novel and transformative approach that delivers ultra-high dose rate radiation (>40 Gy/s), offering the potential to significantly reduce normal tissue toxicity while maintaining tumor control. Despite compelling preclinical and early clinical data, the mechanisms underlying the FLASH effect remain poorly understood, hindering its widespread clinical adoption. The central hypothesis of this proposal is that FLASH RT alters the radiochemical landscape during the first microseconds to milliseconds post-irradiation, leading to a shift in reactive species (RS) composition and dynamics that underlies the observed tissue sparing. Specifically, we propose that FLASH RT increases the yield of aqueous electrons (e⁻aq) and suppresses downstream oxidative stress through altered spur kinetics and radical recombination, resulting in reduced DNA damage and long-term tissue toxicity. The overall objective of this proposal is to elucidate the mechanistic basis of the FLASH effect by directly measuring RS production and biological responses under clinically relevant irradiation conditions. To achieve this, we will develop three complementary platforms: (1) time-resolved absorption spectroscopy for label-free quantification of RS with sub-microsecond resolution, (2) live-cell fluorescence imaging and super-resolution microscopy to map nanoscale RS dynamics and DNA damage repair, and (3) in vivo absorption spectroscopy (ALIVE) to measure RS kinetics in irradiated tissues and correlate them with acute and chronic toxicity endpoints. While our in vitro platforms isolate early radiochemical mechanisms at the nanoscale, live animal models are required to determine how these events propagate through intact tissue architecture. This in vivo context is essential to definitively link initial RS dynamics with macroscopic, long-term physiological outcomes. This work is highly innovative in integrating custom-built optical systems with FLASH-capable beamlines to enable direct, real-time measurement of RS under ultra-high dose rates. Unlike conventional assays relying on probes or indirect surrogates, our approach allows for label-free detection of short-lived species such as e⁻aq, providing unprecedented insight into the earliest radiochemical events that drive biological outcomes. By systematically varying beam parameters, including dose per pulse, mean dose rate, and pulse structure, we will generate a mechanistic map linking physical delivery characteristics to RS production and biological response. The clinical impact of this work is substantial. By identifying the radiochemical and biological signatures that define the FLASH effect, we will enable rational optimization of treatment protocols tailored to specific tissue types and clinical indications. This will support the development of predictive biomarkers for FLASH responsiveness, guide patient selection, and inform dose fractionation strategies. Ultimately, this research will accelerate the safe and effective translation of FLASH RT into routine clinical practice, improving therapeutic outcomes, reducing treatment-related morbidity, and enhancing quality of life for cancer patients.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $369,394 )
2026	2026	WILLIAM MARSH RICE UNIVERSITY	6100 MAIN ST	HOUSTON	TX	77005	HARRIS	USA	Cancer Treatment Research	000	1	6/16/2026	NEW	$369,394
														Subtotal = $369,394

Grand Total All Awards = $369,394

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Imaging and Spectroscopy of Radiation Chemistry in FLASH Radiotherapy to Inform Clinical Translation

Award Number: R01CA315651

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/12/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer